PharmaCorp Rx Inc.
PCRX.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.92% | 951.29% | -10.71% | -9.30% | -5.16% |
| Total Receivables | 225.89% | -- | -- | -- | -- |
| Inventory | 518.78% | -- | -- | -- | -- |
| Prepaid Expenses | 209.74% | 2,100.00% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -2.35% | -- | -- |
| Total Current Assets | 25.96% | 918.65% | -10.39% | -6.11% | -5.16% |
|
|
|||||
| Total Current Assets | 25.96% | 918.65% | -10.39% | -6.11% | -5.16% |
| Net Property, Plant & Equipment | 15.87% | -- | -- | -- | -- |
| Long-term Investments | 210.86% | -- | -- | -- | -- |
| Goodwill | 210.86% | -- | -- | -- | -- |
| Total Other Intangibles | 124.97% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 34.00% | 1,025.40% | -10.39% | -6.11% | -5.16% |
|
|
|||||
| Total Accounts Payable | 24.08% | 558.30% | 27.43% | 14.75% | 85.98% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.31% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 19.33% | 790.81% | 27.43% | 14.75% | 85.98% |
|
|
|||||
| Total Current Liabilities | 19.33% | 790.81% | 27.43% | 14.75% | 85.98% |
| Long-Term Debt | -4.04% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 24.34% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 47.27% | -- | -- | -- | -- |
| Total Liabilities | 21.64% | 2,642.15% | 27.43% | 14.75% | 85.98% |
|
|
|||||
| Common Stock & APIC | 36.29% | 629.33% | -2.47% | 2.43% | -2.11% |
| Retained Earnings | -55.78% | -47.41% | -17.02% | -30.21% | -12.08% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 34.71% | 970.84% | -11.16% | -6.46% | -5.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.71% | 970.84% | -11.16% | -6.46% | -5.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 64.38% | -- | -- | -- | -- |
| Total Equity | 34.92% | 978.27% | -11.16% | -6.46% | -5.92% |
|
|
|||||